Ocul stock price target
TipRanks Ocular Therapeutix (OCUL) PT Lowered to $7 at JMP Securities. 13 Novemeber, 2019. JMP Securities analyst Donald Ellis lowered the price target on Ocular Therapeutix (NASDAQ: OCUL) to $7.00 (from $9.00) while maintaining a Market Outperform rating. Ocular Therapeutix, Inc. (OCUL) Stock Message Board ... Mar 04, 2020 · Add OCUL Price Alert Hide Sticky Hide Intro Moderator: Search This Board: 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003+ Ocular Therapeutix Inc., OCUL Quick Chart - (NAS) OCUL ...
Mar 23, 2020 Real-time trade and investing ideas on Ocular Therapeutix OCUL from the largest community of traders and investors.
7 analysts have issued 12 month price targets for Ocular Therapeutix's stock. Their forecasts range from $3.00 to $11.00. On average, they anticipate Ocular Based on 4 analysts offering 12 month price targets for Ocular Therapeutix in the last 3 months. The average price target is $8.50 with a high forecast of $11.00 Analyst price targets provided by TipRanks. Quick Links. Advanced Charting · After Hours Quote · Analyst Research Find the latest Ocular Therapeutix, Inc. (OCUL) stock quote, history, news and other vital Analysts Estimate Ocular Therapeutix (OCUL) to Report a Decline in Ocular Therapeutix Inc. analyst ratings, historical stock prices, earnings estimates & actuals. OCUL updated stock price target summary. OCUL | Complete Ocular Therapeutix Inc. stock news by MarketWatch. Ocular Therapeutix started at strong buy with $10 stock price target at Raymond James.
Ocular Therapeutix (NASDAQ:OCUL) Given “Buy” Rating at HC ...
The 5 analysts offering 12-month price forecasts for Ocular Therapeutix Inc have The current consensus among 6 polled investment analysts is to Buy stock in Their average twelve-month price target is $7.00, suggesting that the stock has a possible upside of 47.06%. The high price target for OCUL is $11.00 and the 7 analysts have issued 12 month price targets for Ocular Therapeutix's stock. Their forecasts range from $3.00 to $11.00. On average, they anticipate Ocular Based on 4 analysts offering 12 month price targets for Ocular Therapeutix in the last 3 months. The average price target is $8.50 with a high forecast of $11.00 Analyst price targets provided by TipRanks. Quick Links. Advanced Charting · After Hours Quote · Analyst Research
Digging Through Ocular Therapeutix, Inc. (OCUL ...
Analyst price targets provided by TipRanks. Quick Links. Advanced Charting · After Hours Quote · Analyst Research Find the latest Ocular Therapeutix, Inc. (OCUL) stock quote, history, news and other vital Analysts Estimate Ocular Therapeutix (OCUL) to Report a Decline in Ocular Therapeutix Inc. analyst ratings, historical stock prices, earnings estimates & actuals. OCUL updated stock price target summary. OCUL | Complete Ocular Therapeutix Inc. stock news by MarketWatch. Ocular Therapeutix started at strong buy with $10 stock price target at Raymond James. Feb 28, 2020 View OCUL revenue estimates and earnings estimates, as well as analyst Average Recommendation: Overweight, Average Target Price: 6.40 the Fed can heal a coronavirus-stricken stock market that just saw $4.3 trillion Nov 15, 2019 Ocular Therapeutix, Inc. (NASDAQ:OCUL) missed earnings with its latest Following the result, analysts have updated their earnings model, and it would We provide an overview of all open market stock trades for the last Ocular Therapeutix (NASDAQ: OCUL) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and 10 Biggest Price Target Changes For Friday · Raymond James Downgrades Ocular
Ocular Therapeutix, Inc. Common Stock (OCUL) Analyst ...
Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. OCUL: Ocular Therapeutix, Inc. - Price & Consenus Chart ...
Mar 16, 2020 On May 21, 2019, analysts decreased their price target for OCUL shares from 13 to 3. The Average True Range (ATR) for Ocular Therapeutix Inc. Mar 5, 2020 5 analysts offering their recommendations for the stock have an average rating of 2.20, where 1 rate it as a Hold and 0 think it is a “Overweight”. Piper Sandler analyst Joseph Catanzaro raised the firm's price target on Ocular Therapeutix to $11 from $7 and reiterates an Overweight rating on the The stock closed the trading day up 32%, or $1.76, to $7.22. OCUL Ocular Therapeutix.